US5470568A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods and compositions of a polymer (poloxamer) for cell repair
Assignee: Arch Development Corp
•
Filing: 1992-02-13
•
Granted: 1995-11-28
•
Expires: 2012-02-13
Abstract
Abstract Novel methods for prophylaxis and treatment of tissue damage resulting from cell membrane permeabilization are disclosed. Compositions comprising a surface active copolymer are employed to prevent permeabilization or to promote membrane repair. Methods for enhancement of cell survival following membrane permeabilization in vitro are also disclosed, along with methods for increasing the efficacy of transfection of cells with foreign exogenous macromolecules, in particular DNA, also involving treatment of permeabilized cells with a surface active copolymer. Also disclosed are novel methods for prophylaxis and treatment of tissue damage, and for enhancement of cell survival and transfection efficacy, using a surface active copolymer in combination with high energy phosphate compounds which are capable of recharging cellular energy stores and thereby potentiating cell repair and survival. Compositions comprising surface active copolymers for intravenous, intramuscular, and topical use are also disclosed, along with novel compositions comprising a combination of a surface active copolymer and a high energy phosphate compound.
Inventors
- 👤 Raphael C. Lee
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 09:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/74; A61K31/785; A61K31/765; A61K31/77; A61P; A61P39/00; Y; Y10; Y10S; Y10S424/00; Y10S424/13
Claims Analysis
Total Claims: 43
Claim 1
Independent Claim
116 words
A method of reducing animal tissue damage due to radiation comprising treating tissue with a composition consisting essentially of an amount of a surface active copolymer, selected from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxyethylene, that is effective to reduce radiation damage to said tissue by stabilizing cellular membranes or reducing membrane permeability, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer; a high energy phosphate compound; and a pharmaceutically acceptable carrier, wherein said composition is administered either before, during or after the tissue's exposure to a radiation source.
Claim 2
Independent Claim
116 words
A method of reducing animal tissue damage due to radiation comprising treating tissue with a composition consisting essentially of an amount of a surface active copolymer, selected from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxyethylene, that is effective to reduce radiation damage to said tissue by stabilizing cellular membranes or reducing membrane permeability, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer; a high energy phosphate compound; and a pharmaceutically acceptable carrier, wherein said composition is administered either before, during or after the tissue's exposure to a radiation source.
Claim 3
Dependent Claim
11 words
The method of claim 1 wherein said radiation is ionizing radiation.
Claim 4
Dependent Claim
11 words
The method of claim 1 wherein said radiation is nonionizing radiation.
Claim 5
Dependent Claim
14 words
The method of claim 1 wherein the method is practiced on a human subject.
Claim 6
Dependent Claim
59 words
The method of claim 4 further defined as a method for reducing the tissue damage in a human subject undergoing radiation therapy, the method comprising the steps of: (a) identifying a patient who is about to undergo radiation therapy; and (b) administering to said patient an effective amount of the surface active copolymer before, during or after the therapy.
Claim 7
Dependent Claim
81 words
The method of claim 4 further defined as a method for reducing the tissue damage in a human subject undergoing radiation therapy, the method comprising the steps of: (a) identifying a patient who has undergone radiation therapy and has suffered damage to nondiseased tissues as a consequence thereof; and (b) administering to said patient an effective amount of the surface active copolymer in order to treat said damaged nondiseased tissue and to prevent or minimize further damage to said nondiseased tissue.
Claim 8
Dependent Claim
15 words
The method of claim 1 wherein the high energy phosphate compound comprises ATP-MgCl 2 .
Claim 9
Dependent Claim
13 words
The method of claim 1 wherein the high energy phosphate compound comprises phosphocreatine.
Claim 10
Dependent Claim
24 words
The method of claim 1 wherein the composition is administered to a subject intravenously, intramuscularly or topically in order to treat the affected tissue.
Claim 11
Dependent Claim
76 words
The method of claim 1 wherein the poloxamer has the following general formula: HO--(C.sub.2 H.sub.4 O).sub.b --(C.sub.3 H.sub.6 O).sub.a --(C.sub.2 H.sub.4 O).sub.b --H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) a has a molecular weight of approximately 950 to 4,000, and b is an integer such that the hydrophile represented by (C 2 H 4 O) b constitutes approximately 45% to 95% by weight of the poloxamer.
Claim 12
Dependent Claim
75 words
The method of claim 1 wherein the poloxamer has the following general formula: HO--(C.sub.2 H.sub.4 O).sub.b --(C.sub.3 H.sub.6 O).sub.a --(C.sub.2 H.sub.4 O).sub.b --H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 1,750 to 3,500, and b is an integer such that the hydrophile represented by (C 2 H 4 O) b constitutes approximately 50% to 90% by weight of the poloxamer.
Claim 13
Independent Claim
103 words
A method for repair of permeability damage to cells following membrane permeabilization comprising administering to permeabilized cells, in a dosage form other than topical, a composition comprising an amount of a surface active copolymer, selected from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxethylene, that is effective to stabilize the membranes of said cells or reduce their permeability, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer, the copolymer being administered before, during or after membrane permeabilization.
Claim 14
Independent Claim
103 words
A method for repair of permeability damage to cells following membrane permeabilization comprising administering to permeabilized cells, in a dosage form other than topical, a composition comprising an amount of a surface active copolymer, selected from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxethylene, that is effective to stabilize the membranes of said cells or reduce their permeability, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer, the copolymer being administered before, during or after membrane permeabilization.
Claim 15
Dependent Claim
26 words
The method of claim 12 wherein membranes of said cells are permeabilized by irradiation, by osmotic means, by use of a detergent, or by mechanical means.
Claim 16
Dependent Claim
14 words
The method of claim 12 wherein said composition further comprises a high-energy phosphate compound.
Claim 17
Dependent Claim
14 words
The method of claim 14 wherein the high-energy phosphate compound comprises ATP-MgCl 2 .
Claim 18
Dependent Claim
12 words
The method of claim 14 wherein the high-energy phosphate compound comprises phosphocreatine.
Claim 19
Dependent Claim
14 words
The method of claim 12 further comprising incorporating exogenous macromolecules into the permeabilized cells.
Claim 20
Dependent Claim
24 words
The method of claim 17 wherein said exogenous molecules are DNA molecules, and wherein the DNA molecules are incorporated into the cell by transfection.
Claim 21
Dependent Claim
13 words
The method of claim 17 wherein the exogenous macromolecules comprise DNA antisense molecules.
Claim 22
Independent Claim
130 words
A method for increasing the efficiency by which exogenous macromolecules are incorporated into living cells comprising the following steps: (a) permeabilizing the membranes of the cells; (b) exposing the cells to the exogenous macromolecules; and (c) either before, during or after the performance of steps (a) and (b), administering to the living cells, in a dosage form other than topical, a composition comprising an amount of a surface active copolymer, selected or from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxyethylene, that is effective to stabilize the membranes of said cells or reduce their permeabilization, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer.
Claim 23
Independent Claim
130 words
A method for increasing the efficiency by which exogenous macromolecules are incorporated into living cells comprising the following steps: (a) permeabilizing the membranes of the cells; (b) exposing the cells to the exogenous macromolecules; and (c) either before, during or after the performance of steps (a) and (b), administering to the living cells, in a dosage form other than topical, a composition comprising an amount of a surface active copolymer, selected or from the group consisting of poloxamer, meroxapol, poloxamine and a polyol of trimethylolpropane and polyoxyethylene, that is effective to stabilize the membranes of said cells or reduce their permeabilization, the surface active copolymer having a molecular weight of between about 2,000 and about 20,000 Daltons and from about 45% to 95% hydrophobic groups by weight of the copolymer.
Claim 24
Dependent Claim
24 words
The method of claim 20 wherein said exogenous macromolecules comprise DNA molecules, and wherein the DNA molecules are incorporated into the cells by transfection.
Claim 25
Dependent Claim
27 words
The method of claim 20 wherein said exogenous macromolecules comprise DNA antisense molecules, and wherein said DNA antisense molecules are incorporated into the living cells by transfection.
Claim 26
Dependent Claim
14 words
The method of claim 1, wherein the selected surface active copolymer is a poloxamer.
Claim 27
Dependent Claim
11 words
The method of claim 23, wherein the poloxamer is poloxamer 188.
Claim 28
Dependent Claim
11 words
The method of claim 23, wherein the poloxamer is poloxamer 1107.
Claim 29
Dependent Claim
14 words
The method of claim 1, wherein the selected surface active copolymer is a meroxapol.
Claim 30
Dependent Claim
14 words
The method of claim 1, wherein the selected surface active copolymer is a poloxamine.
Claim 31
Dependent Claim
18 words
The method of claim 1, wherein the selected surface active copolymer is a polyol of trimethylolpropane and polyoxyethylene.
Claim 32
Dependent Claim
14 words
The method of claim 12, wherein the selected surface active copolymer is a poloxamer.
Claim 33
Dependent Claim
11 words
The method of claim 29, wherein the poloxamer is poloxamer 188.
Claim 34
Dependent Claim
11 words
The method of claim 29, wherein the poloxamer is poloxamer 1107.
Claim 35
Dependent Claim
14 words
The method of claim 12, wherein the selected surface active copolymer is a meroxapol.
Claim 36
Dependent Claim
14 words
The method of claim 12, wherein the selected surface active copolymer is a poloxamine.
Claim 37
Dependent Claim
18 words
The method of claim 12, wherein the selected surface active copolymer is a polyol of trimethylolpropane and polyoxyethylene.
Claim 38
Dependent Claim
14 words
The method of claim 20, wherein the selected surface active copolymer is a poloxamer.
Claim 39
Dependent Claim
11 words
The method of claim 35, wherein the poloxamer is poloxamer 188.
Claim 40
Dependent Claim
11 words
The method of claim 35, wherein the poloxamer is poloxamer 1107.
Claim 41
Dependent Claim
14 words
The method of claim 20, wherein the selected surface active copolymer is a meroxapol.
Claim 42
Dependent Claim
14 words
The method of claim 20, wherein the selected surface active copolymer is a poloxamine.
Claim 43
Dependent Claim
18 words
The method of claim 20, wherein the selected surface active copolymer is a polyol of trimethylolpropane and polyoxyethylene.
References Cited (Backward Citations)
US29909A
Cited
US2674619A
Cited
US2854378A
Cited
US3089818A
Cited
US3140232A
Cited
US3740421A
Cited
DE1930957A1
Cited
AU4362868A
Cited
US3641240A
Cited
US3590125A
Cited
US3577522A
Cited
US3980772A
Cited
US3867521A
Cited
US4073886A
Cited
US3956259A
Cited
US4179337A
Cited
FR2267112A1
Cited
US4105650A
Cited
US4100271A
Cited
US4305922A
Cited
US4186253A
Cited
US4395393A
Cited
US4407790A
Cited
WO1985002116A1
Cited
US4600652A
Cited
EP0200467A2
Cited
US5028599A
Cited
US5078995A
Cited
US4801452A
Cited
US4837014A
Cited
US4873083A
Cited
US4879109A
Cited
US4897263A
Cited
US4937070A
Cited
US5152979A
Cited
US5089260A
Cited
US5017370A
Cited
WO1987006831A1
Cited
WO1987006836A1
Cited
US5039520A
Cited
US5030448A
Cited
US5041288A
Cited
US5080894A
Cited
US5047236A
Cited
US5064643A
Cited
US5071649A
Cited
US5032394A
Cited
US5045468A
Cited
US5075333A
Cited
US5002965A
Cited
US4997664A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-11-27 | 1999-05-29 | 1999-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-11-27 | 2003-05-29 | 2003-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-11-27 | 2007-05-29 | 2007-11-28 | $7700.00 | Window Closed / Lapsed |